{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:49:24Z","timestamp":1781070564293,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03886-3","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:44:55Z","timestamp":1738331095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit\/hyperactivity disorder"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-4810","authenticated-orcid":false,"given":"I\u015f\u0131l Merve","family":"Torun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-9262","authenticated-orcid":false,"given":"Zeynep","family":"Vatansever Pinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9572-6730","authenticated-orcid":false,"given":"\u015eeyma","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"3","key":"3886_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2165\/11599580-000000000-00000","volume":"72","author":"AC Childress","year":"2012","unstructured":"Childress AC, Berry SA. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents. Drugs. 2012;72(3):309\u201325.","journal-title":"Drugs"},{"key":"3886_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12991-020-00271-w","volume":"19","author":"G Ayano","year":"2020","unstructured":"Ayano G, Yohannes K, Abraha M. Epidemiology of attention-deficit\/hyperactivity disorder (ADHD) in children and adolescents in Africa: a systematic review and meta-analysis. Ann Gen Psychiatry. 2020;19:21.","journal-title":"Ann Gen Psychiatry"},{"key":"3886_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","volume":"128","author":"SV Faraone","year":"2021","unstructured":"Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789\u2013818.","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"3886_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry. 2018;5(10):824\u201335.","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"3886_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727\u201338.","journal-title":"Lancet Psychiatry"},{"key":"3886_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/NDT.S65735","volume":"11","author":"J Martinez-Raga","year":"2015","unstructured":"Martinez-Raga J, Knecht C, de Alvaro R. Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder. Neuropsychiatr Dis Treat. 2015;11:1359\u201370.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"3886_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","volume":"129","author":"M Wang","year":"2007","unstructured":"Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007;129(2):397\u2013410.","journal-title":"Cell"},{"issue":"11","key":"3886_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMra1917069","volume":"383","author":"S Cortese","year":"2020","unstructured":"Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050\u20136.","journal-title":"N Engl J Med"},{"issue":"5035","key":"3886_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991;254(5035):1178\u201381.","journal-title":"Science"},{"issue":"9","key":"3886_CR10","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","volume":"36","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A. Choroidal vascularity index in central serous chorioretinopathy. Retina. 2016;36(9):1646\u201351.","journal-title":"Retina"},{"key":"3886_CR11","unstructured":"M W. Corneal topography in the Wavefront Era; a Guide for Clinical Application, ed Thorofare, NJ, Slack2006."},{"issue":"5","key":"3886_CR12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.4103\/ijo.IJO_2966_21","volume":"70","author":"P Bing\u00f6l-K\u0131z\u0131ltun\u00e7","year":"2022","unstructured":"Bing\u00f6l-K\u0131z\u0131ltun\u00e7 P, Y\u00fcr\u00fcmez E, Atilla H. Does methylphenidate treatment affect functional and structural ocular parameters in patients with attention deficit hyperactivity disorder? - a prospective, one year follow-up study. Indian J Ophthalmol. 2022;70(5):1664\u20138.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"3886_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3928\/01913913-20230809-01","volume":"61","author":"M Icoz","year":"2024","unstructured":"Icoz M, Yorgun MA, Bayhan GI, Icoz SGG, Yahsi A. Assessment of the Choroidal Vascular structure in Multisystem Inflammatory Syndrome in Children. J Pediatr Ophthalmol Strabismus. 2024;61(2):120\u20136.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"3886_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/11206721231207507","volume":"34","author":"P Gultutan","year":"2024","unstructured":"Gultutan P, Nalcacioglu P, Icoz M, Yilmaz D, Kurt ANC. Ocular hemodynamics in epileptic children treated with antiepileptic drugs. Eur J Ophthalmol. 2024;34(3):843\u201351.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3886_CR15","first-page":"42","volume":"30","author":"F \u00dcnal","year":"2019","unstructured":"\u00dcnal F, \u00d6ktem F, \u00c7etin \u00c7uhadaro\u011flu F, \u00c7engel K\u00fclt\u00fcr SE, Akdemir D, Foto \u00d6zdemir D, et al. [Reliability and validity of the schedule for affective disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)]. Turk Psikiyatri Derg. 2019;30(1):42\u201350.","journal-title":"Turk Psikiyatri Derg"},{"issue":"4","key":"3886_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1517\/14656566.1.4.815","volume":"1","author":"LB Cantor","year":"2000","unstructured":"Cantor LB. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. Expert Opin Pharmacother. 2000;1(4):815\u201334.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3886_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1476-5381.2011.01533.x","volume":"165","author":"R Gilsbach","year":"2012","unstructured":"Gilsbach R, Hein L. Are the pharmacology and physiology of \u03b1\u2082 adrenoceptors determined by \u03b1\u2082-heteroreceptors and autoreceptors respectively? Br J Pharmacol. 2012;165(1):90\u2013102.","journal-title":"Br J Pharmacol"},{"key":"3886_CR18","doi-asserted-by":"crossref","unstructured":"Adkins JC, Balfour JA, Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs Aging. 1998;12(3):225\u201341.","DOI":"10.2165\/00002512-199812030-00005"},{"issue":"4","key":"3886_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/dmd.30.4.421","volume":"30","author":"AA Acheampong","year":"2002","unstructured":"Acheampong AA, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. Drug Metab Dispos. 2002;30(4):421\u20139.","journal-title":"Drug Metab Dispos"},{"issue":"18","key":"3886_CR20","doi-asserted-by":"publisher","first-page":"e37416","DOI":"10.1016\/j.heliyon.2024.e37416","volume":"10","author":"A Xiang","year":"2024","unstructured":"Xiang A, Peng Z, He H, Meng X, Luo Y, Yang J, et al. The potential of brimonidine for myopia treatment: targeting MMP-2 to regulate choroidal thickness and control eye growth. Heliyon. 2024;10(18):e37416.","journal-title":"Heliyon"},{"issue":"1","key":"3886_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12886-023-03107-9","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Q. Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report. BMC Ophthalmol. 2023;23(1):405.","journal-title":"BMC Ophthalmol"},{"issue":"21","key":"3886_CR22","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.visres.2008.06.023","volume":"48","author":"DA Atchison","year":"2008","unstructured":"Atchison DA, Markwell EL. Aberrations of emmetropic subjects at different ages. Vis Res. 2008;48(21):2224\u201331.","journal-title":"Vis Res"},{"issue":"6","key":"3886_CR23","first-page":"1390","volume":"42","author":"JS McLellan","year":"2001","unstructured":"McLellan JS, Marcos S, Burns SA. Age-related changes in monochromatic wave aberrations of the human eye. Invest Ophthalmol Vis Sci. 2001;42(6):1390\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3886_CR24","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0886-3350(03)00643-6","volume":"29","author":"L Wang","year":"2003","unstructured":"Wang L, Koch DD. Ocular higher-order aberrations in individuals screened for refractive surgery. J Cataract Refract Surg. 2003;29(10):1896\u2013903.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"3886_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1364\/JOSAA.19.000137","volume":"19","author":"P Artal","year":"2002","unstructured":"Artal P, Berrio E, Guirao A, Piers P. Contribution of the cornea and internal surfaces to the change of ocular aberrations with age. J Opt Soc Am Opt Image Sci Vis. 2002;19(1):137\u201343.","journal-title":"J Opt Soc Am Opt Image Sci Vis"},{"issue":"1","key":"3886_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/OPX.0000000000001160","volume":"95","author":"N Zhang","year":"2018","unstructured":"Zhang N, Liu L, Yang B, Ma W, Wang X, Ye W, et al. Higher-order aberrations in children and adolescents of Southwest China. Optom Vis Sci. 2018;95(1):53\u20139.","journal-title":"Optom Vis Sci"},{"issue":"12","key":"3886_CR27","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1167\/iovs.02-1042","volume":"44","author":"I Brunette","year":"2003","unstructured":"Brunette I, Bueno JM, Parent M, Hamam H, Simonet P. Monochromatic aberrations as a function of age, from childhood to advanced age. Invest Ophthalmol Vis Sci. 2003;44(12):5438\u201346.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03886-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:45:00Z","timestamp":1738331100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03886-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3886"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03886-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation was approved by the Human Research Ethics Committee of Haydarpasa Numune Training and Research Hospital (HNEAH-KAEK 2023\/KK\/167) and conducted in accordance with the Helsinki Declaration. Before including any subjects, informed consent to participate was obtained from the parents or legal guardians of any participant under the age of 16.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}